KRISTINA TRAFELET: Open Payments
NPI 1881163046 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$416 in 14 payments from 5 companies in 2025. Trend: 2023 $3,542 · 2024 $1,031 · 2025 $416
Food & beverage: $416
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $199 |
| Stemline Therapeutics Inc. | 1 | $125 |
| Incyte Corporation | 2 | $52 |
| Daiichi Sankyo Inc. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: ELZONRIS, EPKINLY, IMBRUVICA, MONJUVI, VENCLEXTA, JAKAFI, Enhertu, VRAYLAR.
Industry payments across AZ — which companies pay providers there.
